Our Pricing

First Week on Mounjaro: What to Expect Day 1-7

Starting your first week on mounjaro uk can feel daunting, but knowing what to expect each day helps you prepare for the journey ahead. At Cured Pharmacy, our UK clinical team has supported thousands of patients through their initial Mounjaro experience, and this comprehensive guide draws on real patient outcomes and clinical trial data to help you navigate days 1-7 with confidence.

Day 1: Your First Mounjaro Injection

Your first Mounjaro injection typically uses the 2.5mg starter dose, which is specifically designed to help your body adjust gradually to tirzepatide [1]. Most patients report minimal immediate effects on day one, as the medication takes several hours to reach peak concentration in your bloodstream. The injection itself is subcutaneous, meaning you'll administer it into the fatty tissue of your abdomen, thigh, or upper arm using the KwikPen device.

Within 4-6 hours of your first injection, some patients notice subtle appetite changes — you might feel satisfied earlier during meals or experience reduced food cravings between meals [2]. These effects are mild during week one compared to what you'll experience at higher maintenance doses. It's completely normal to feel anxious about your first self-injection, but the KwikPen is designed for ease of use with a hidden needle and simple click mechanism.

Common sensations on day one include mild injection site tenderness, which resolves within 24 hours in most cases. You may also notice slight fatigue as your body begins responding to the dual GIP/GLP-1 receptor activation that makes tirzepatide unique among weight loss medications licensed in the UK [1].

Injection Technique Tips for Day One

Rotate your injection sites from the start to minimise skin irritation. If injecting into your abdomen, stay at least 5cm away from your belly button and alternate between left and right sides each week. Allow the pen to reach room temperature for 30 minutes before injecting, as cold medication can increase discomfort. Pinch the skin gently, insert the pen at a 90-degree angle, and hold for 10 seconds after pressing the button to ensure full dose delivery.

Days 2-3: Early Metabolic Adjustments

During days 2-3, tirzepatide continues building in your system, and you may notice more pronounced appetite suppression. Many patients report feeling comfortably full after smaller portions than usual, which is the intended therapeutic effect of GLP-1 receptor agonists [2]. This isn't forced restriction — rather, your brain's satiety signals are being restored to healthier patterns.

Mild nausea is the most commonly reported side effect during this window, affecting approximately 20-30% of patients in the SURMOUNT-1 trial [3]. If you experience nausea, it typically manifests as a gentle queasiness rather than severe discomfort, and usually improves significantly by week 2-3 as your body adapts. Eating smaller, more frequent meals and avoiding high-fat foods can help manage this adjustment period.

Some patients notice changes in bowel habits during days 2-3, including softer stools or mild constipation. These gastrointestinal effects are temporary for most people and reflect tirzepatide's action on gastric emptying — the medication slows how quickly food moves through your digestive system, which contributes to prolonged fullness [1]. Staying well-hydrated with at least 2 litres of water daily helps minimise these effects.

Days 4-5: Recognising Early Changes

By the middle of your first week on Mounjaro, you're likely noticing consistent appetite reduction and potentially some early weight changes. It's important to understand that any weight loss during week one is primarily water weight and initial glycogen depletion, not fat loss [4]. The significant body composition changes seen in clinical trials — averaging 15-22.5% total body weight reduction — occur gradually over 40-72 weeks [1][3].

Energy levels vary considerably between patients during days 4-5. Some report feeling more energetic as blood glucose stabilises, whilst others experience mild fatigue as their body adjusts to reduced calorie intake. This is entirely normal and typically resolves by week 2-3. If you're used to consuming significantly more calories than you currently feel like eating, your body needs time to adapt its energy metabolism.

Food preferences may shift noticeably by day 4-5. Many patients report reduced interest in high-fat, high-sugar foods and increased satisfaction from protein-rich meals. This isn't willpower — it's the neurological effect of GLP-1 receptor activation in appetite-regulating brain regions [2]. Listen to these signals rather than forcing yourself to eat when you're genuinely not hungry, but ensure you're still meeting minimum nutritional requirements.

Nutritional Guidelines for Week One

Aim for at least 1200-1500 calories daily even if your appetite is significantly reduced, focusing on lean proteins, vegetables, and whole grains. Protein intake is particularly important — target 80-100g daily to preserve muscle mass during weight loss. Avoid skipping meals entirely, as this can worsen nausea and lead to blood sugar fluctuations. If solid foods feel unappealing, protein shakes or Greek yoghurt can help you meet nutritional needs whilst respecting your reduced appetite.

Days 6-7: Completing Your First Week

As you approach the end of your first week on Mounjaro, most initial side effects begin stabilising. Nausea typically peaks during days 2-4 and then gradually improves, though individual experiences vary [3]. By day 7, you've established your injection routine and have a clearer sense of how your body responds to the 2.5mg starter dose.

Weight changes during the first seven days typically range from 0.5-2kg, though this varies significantly based on starting weight, diet, and individual metabolism [4]. Remember that the starter dose is intentionally low to minimise side effects whilst your body adjusts — you'll move to 5mg for your second injection, which is when more substantial effects typically begin. Clinical trials show that weight loss accelerates progressively as doses increase to therapeutic levels of 10mg or 15mg over subsequent months [1][3].

Day 7 is an ideal time to reflect on your experience and prepare questions for your UK prescriber at your next check-in. Note any persistent side effects, changes in medication tolerance, or concerns about your response to treatment. All patients at Cured Pharmacy have ongoing access to our clinical team, and adjustments to your treatment plan can be made based on your individual response and tolerability.

Managing First Week Side Effects

The most common side effects during your first week on Mounjaro include nausea (20-30% of patients), mild constipation or diarrhoea (15-20%), fatigue (10-15%), and injection site reactions (8-12%) [3]. These figures come from the SURMOUNT clinical trial programme and represent experiences at all dose levels, so your 2.5mg starter dose typically produces milder effects than these averages suggest.

For nausea management, eat smaller meals every 3-4 hours rather than three large meals, avoid lying down immediately after eating, and choose bland, easily digestible foods like toast, rice, or bananas during the adjustment period. Ginger tea and peppermint can provide natural relief. If nausea persists beyond week 2 or becomes severe enough to prevent adequate nutrition, contact your prescriber — dose adjustments or anti-nausea medication may be appropriate.

Gastrointestinal side effects often respond well to dietary modifications. For constipation, increase fibre intake gradually through vegetables and whole grains, maintain excellent hydration, and consider a gentle fibre supplement if needed. For loose stools, reduce dietary fat temporarily and avoid known trigger foods. Most GI symptoms improve significantly by week 3-4 as your digestive system adapts to altered gastric emptying rates [2].

Injection site reactions — redness, mild swelling, or tenderness — affect fewer than 10% of patients and typically resolve within 48 hours [1]. Rotating injection sites consistently, using proper technique, and applying a cool compress after injection can minimise these effects. If you develop persistent lumps, significant swelling, or signs of infection at injection sites, contact your pharmacy or prescriber promptly.

When to Contact Your Prescriber

Seek immediate medical attention if you experience severe abdominal pain (which could indicate pancreatitis, though this affects fewer than 0.2% of patients), persistent vomiting preventing fluid intake, signs of allergic reaction including facial swelling or difficulty breathing, or vision changes [3]. Contact your Cured Pharmacy clinical team for non-emergency concerns like persistent nausea affecting nutrition, unusual fatigue lasting beyond week two, or questions about dose escalation timing.

What Happens After Week One

Your second Mounjaro injection will remain at 2.5mg, maintaining the starter dose for a full four weeks before escalating to 5mg. This gradual titration schedule, recommended by the MHRA and supported by clinical trial protocols, significantly reduces side effect severity compared to faster dose increases [1]. Most patients tolerate the 2.5mg dose well by their third or fourth injection, with initial side effects largely resolved.

Weight loss typically accelerates from week 4 onwards as you progress through dose escalations. In the SURMOUNT-1 trial, patients on the maintenance dose of 15mg tirzepatide achieved an average 20.9% body weight reduction over 72 weeks, with most weight loss occurring between weeks 12-52 [3]. Your UK prescriber will determine your optimal maintenance dose based on efficacy, tolerability, and individual response, with options of 5mg, 10mg, or 15mg weekly injections.

Ongoing monitoring is essential throughout your Mounjaro treatment. At Cured Pharmacy, patients receive regular clinical check-ins to assess progress, manage any emerging side effects, and adjust treatment plans as needed. You'll track weight changes, discuss lifestyle modifications including diet and exercise, and ensure the medication continues working effectively. Mounjaro is most effective when combined with a reduced-calorie diet and increased physical activity, as demonstrated across all major tirzepatide clinical trials [1][3][4].

Long-term success with Mounjaro requires commitment beyond the first week. This medication is a tool that works by restoring normal appetite regulation and improving metabolic function, but sustainable weight loss depends on establishing healthier eating patterns and activity levels that you can maintain. Your clinical team at Cured Pharmacy supports you throughout this journey, from your nervous first injection through to achieving and maintaining your weight loss goals.

Starting Mounjaro at Cured Pharmacy

Mounjaro is available from £135.00 at Cured Pharmacy following a free online consultation with our UK-registered prescribers. The assessment takes under 3 minutes and evaluates your medical history, current medications, and suitability for tirzepatide treatment. If approved, your medication is dispensed from our GPhC-registered pharmacy and delivered in discreet packaging directly to your door. All patients receive comprehensive injection training materials, ongoing clinical support, and transparent pricing with no hidden fees.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. https://doi.org/10.1016/j.molmet.2020.101102
3. Garvey, W. T., Frias, J. P., Jastreboff, A. M., et al. (2023). Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. The Lancet, 402(10402), 613–626. https://doi.org/10.1016/S0140-6736(23)01200-X
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, dietary modifications, and lifestyle changes. Side effects vary between patients — contact your prescriber if you experience persistent or severe symptoms.